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Abstract. In certain cancer chemoprevention experiments both the number of observed 
tumors per animal and their times to detection are used in subsequent statistical analyses. 
The mathematical models used to represent these experiments usually include the Poisson 
distribution to characterise the tumor multiplicity data. Very often however, there is excess 
variance due to interanimal heterogeneity of tumor response. Thus, the number of induced 
tumors is better characterieed by the negative binomial distribution. In this paper we 
modify an existing statistical technique, which explicitly acknowledges the confounding 
inherent in these systems, in order to provide a more efficient procedure for utilieing the 
information in a sample and to more accurately assess treatment effects. 
1. INTRODUCTION 
This paper is concerned with the statistical analysis of cancer chemoprevention exper- 
iments in which there is heterogeneous Poisson sampling and type I censoring. The 
objective of these experiments is to assess the effects of various diets on incidence rates 
of cancer. The two primary response variables used in the statistical analyses are the 
number of observed cancers and their times to detection. 
The analysis of these experiments is made difficult by the (usually) large animal-to- 
animal variation in susceptibility to tumor development and the confounding of tumor 
number and tumor time distributions. The %are event” or Poisson distribution is the 
natural choice to characterize the number of induced tumors. However, frequently the 
sample variance significantly exceeds the sample mean number of tumors per animal. 
Thus, the negative binomial distribution is more appropriate. 
The confounding occurs because the experiments are terminated before all induced 
tumors are observed. Fewer observed tumors in a treatment group compared with a 
control group may be due to a decreased number of induced tumors, a slower tumor 
growth rate, or both. 
2. BACKGROUND 
In the investigations we model here, both the number of observed tumors per animal 
and their times to detection are available for analysis. These studies involve the chemical 
induction of tumors in the target tissue (mammary glands) in experimental animals (rats) 
by a “single n exposure to a carcinogen [l] [2]. A nimals are usually assigned to treatment 
groups 1 week following exposure to a carcinogen [3] and treatment diets are directed at 
the tumor developmental process. 
Animals are examined for tumors at frequent intervals, usually beginning 2-3 weeks 
post-carcinogen exposure. The date of first observation and the location of each detected 
tumor is recorded. 
The mathematical model we use to characterize experiments of this type is based on a 
two-stage theory of tumorigenesis. The process of initiation and promotion are associated 
with a single promotion state which is assumed to be independent of the progression or 
development stage. 
We assume that an experiment has duration t’ and that exposure to a carcinogen 
results in the initiation and promotion of X malignant tumors in the target tissue which 
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progress to a size which is detectable by palpation. Due to frequent palpations, we assume 
detection times correspond with the times the tumors reach palpable size. Let the sample 
Tl,T2,... , TX be the detection times of all induced cancers in an experimental animal. 
The observed detection times are those that satisfy Tj 5 t*. 
The experiments are usually short (120-200 days) in comparison to the total lifetime 
of the animals and the induced mammary cancers are generally not life-threatening. 
Thus, most animals survive until the end of the experiment. At the termination of 
the experiment, all animals are sacrificed to permit histopathological confirmation of 
observable tumors. 
The termination of the experiment interrupts the appearance of tumors already in- 
duced, not the tumor generating process. Latent tumors would have appeared had the 
experiment lasted for a longer period of time. This aspect of censoring in these systems 
in which multiple tumors occur leads to the confounding of tumor number and time to 
detection parameters. 
In this paper we extend the results in [4] and [5], which address the confounding issue, 
to account for animal-toanimal variation in susceptibility to tumor development. The 
resulting model is more realistic and applicable to a wider variety of experiments. 
3. THE MODEL 
In the experiments we are most familiar with, the tumor multiplicity data is best char- 
acterized by a generalized Poisson distribution. This suggests the use of the negative 
binomial distribution, which has been used in similar models that involve heterogeneous 
Poisson sampling (61 [7] 181. W e a so 1 assume that the times to detection can be charac- 
terized by a gamma distribution. Our goal is to estimate the parameters that specify the 
underlying distributions, and then to compare treatments based on these estimates. 
1. 
We assume the following mathematical model characterizes the experiment: 
The number of promoted tumors per animal, X, has a negative binomial distribution 
with parameters m and k (m > 0, k > 0). The probability mass function for the 
random variable X is 
2. 
3. 
4. 
E(X) = m, Var(X) = m + m2/k. The value of the exponent k is an indication 
of the heterogeneity of the system. Small values of k imply large heterogeneity and 
as k -+ 00, p(z; m, k) approaches a Poisson probability distribution function, with 
parameter (mean) m. 
The time to detection, T, of a randomly selected tumor has a gamma distribution with 
parameters OL and p (o > 0, p > 0). Let f(t; a, p) and F(t; a, ,L?) be the probability 
density function (pdf) and cumulative distribution function (cdf), respectively, for T, 
where 
f(t;a,p) = { ,““““‘“=-I exp(-tlP) t,t;e;wise 
All animals survive until the end of the experiment, t’. 
Tumors are initiated and promoted independently of one another, and promoted tu- 
mors grow (progress) independently of one another. 
The method of maximum likelihood will be used to estimate the mean number of 
promoted tumors per animal, m, the exponent, k, and the detection time parameters (Y 
and p, which are related to the rate of tumor development. Let J(t*) be the number of 
observed tumors per animal during the entire experiment. J(t*) has a negative binomial 
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distribution with mean mF(t*; CY, /?) and exponent k, and so the probability of observing 
z tumors at time t* in a randomly selected animal is given by 
‘+b*) = d = P(” 1 t*) = ‘$$_;’ (,,.$(t*. i a) + k 
I 9 
rnF(t*; a, p) = 
mF(t*; a, /3) + k > 
Consider a treatment group of n animals and let zi (; = 1,. . . , n) be the number of 
observed tumors in animal i. Let tij (i = 1,. . . ,zi) be the observed time to detection 
of tumor j in animal i. The likelihood of observing z; tumors in animal i at times 
ti1,e.a , tizi is given by 
Li(m, k, LY, a) = Pr[J(t*) = hi] . f(til 1 t’) ‘. . f(tizi 1 t*) 
= p(z; 1 t*) . 
i 
fi tGml eXp(-tij/p)/[palT(CY)] /F(t*; a,p)zi 
j=l 
where f(tij ) t’) = f(tij; a,p)/F(t*; a, P) is the likelihood of detection time tij given the 
duration of the experiment is t*. 
The &&hood function for the entire treatment group is calculated by multiplying the 
individual animal likelihood functions together. Thus, L(m, k, o, a) = ny=, J% (my k, a, P).I 
Let C = sr! . ..z.!, sr = Cy=, zir ~2 = Cy__, CgLI ln(tii), as = Cy’r CgLr tij* Then 
the log-likelihood function can be written as 
i=l 
+ sr(lnm - ml?(o) - crlnp) - (sr + nk)(ln(mF(t*;a,P) + k))+ 
+ (a - l)s2 - s3/p. 
(1) 
Let 8’ = F(t*;&,$). The identifiable parameters m, k,a, and p have unique maxi- 
mum likelihood estimates t%, I, h, and /? [9] w K must satisfy the following system of h’ h 
equations: 
7% = sl/(nP) (2) 
&(i,+&) + 
i=l 
n [-ui(i)+h (--$)] =o 
( 
A 
s1 +(&)+lnlj++~ 
) 
-ss=O 
sl(&/?+$$ -s3=o 
where +(y) = I”(y)/I’(y) is the digamma function. 
4. PARAMETER ESTIMATION 
This model and estimation procedure provide the experimenter with simultaneous 
maximum likelihood estimates. r% is an estimate of the mean number of promoted 
tumors per animal, the number of tumors we would expect to see if the experiment were 
allowed to continue to infinity. Prom equation (2) we see that 6a is a function of both 
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the number of observed tumors at time t*, 91, and the detection time parameters, P. 
As t’ + 00, $’ -+ 1, and 61 -+ sr/n = Z, the sample mean number of observed tumors 
per animal. Since most experiments end before all promoted tumors are observed, @ 
is generally less than 1, which causes the estimate for m to be larger than 7% Thus, 
this estimation procedure does address the confounding problem, and also heterogeneous 
Poisson sampling, and leads to a more accurate assessment of a given chemopreventative 
agent. 
In order to estimate m, k,o, and p, we soJve equations (4) and (5) simultaneously 
(using numerical procedures) to yield & and /3. 61 fol.lows from equation (2). Equation 
(3) can be solved for k using a computer supplied algorithm also. 
In order to assess the rate of tumor development, we would like to estimate p = orp, 
the mean time to detection. Larger values of I-( suggest a slower tumor growth rate. Using 
a theorem from [lo], the maximum likelihood estimate for p is fi = S$ (65 = t% + ti2/i 
estimates the variance of X, and 6$ = &a” estimates the variance of 7’). Treatment 
comparisons are based on the two parameters m and ~1. 
5. TREATMENT COMPARISONS 
Let Y’ be the transpose of the vector Y and assume that n, the number of animals 
in the group is large. The maximum likelihood estimators Y’ = (Sa, i, &,I) and Qt = 
(r%,p) are asymptotically multivariate normally distributed and converge in probability 
to (m,k, o,/3) and (m,p), respectively. In order to compare treatments in terms of 
(m,p) we need the variance-covariance matrix for the estimator Q. However, we must 
first consider the estimator Y. 
Let E+ denote the variance covariance matrix for Y. Let F = F(t*; a, a), then Ep is 
approximated by ([ 111 p.59) 
where u = mF+k and E [$‘(k + X)] = Ijl’(k+mF)+~$“‘(k+mF) (mF + $$) = W. 
The variance-covariance matrix for Q can be approximated by ([12] p.160) 
An estimate of Ea is obtained by substituting T%, I, 6, and fi for m, k, CY, and p. This 
approximate variance-covariance matrix for li can be used in applying standard mul- 
tivariate techniques to obtain a confidence region (ellipse) for (m,p) or to conduct a 
hypothesis test of the form Hc : ut = uk = (mc, ~0) versus H, : u # ug. 
We now assume there are k 2 2 groups in the experiment and consider procedures 
for treatment comparisons. We use a likelihood ratio test to determine if all groups 
arise from the same population, or equivalently, the vector of parameters (m, k, a, /3) 
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is the same for all groups. If we reject Ho in favor of H,: at least two of the samples 
originate from different populations, then further statistical analysis is required to isolate 
the groups contributing to this overall experiment effect, and to isolate which factor(s) 
(m and/or p) is( are contributing to an established group difference. ) 
Using the procedure described above we obtain estimates of the distribution parameters 
ti,&,Bi,fii, i = 1 >**a , g for each group, and the pooled estimates r?aP, 5, &,, &. Under 
the null hypothesis, the likelihood of the sample is L(fio) = L(r%,, 5, &,, BP), and under 
the alternative hypothesis, L(fia) = nd, Li(ti,&,&i,Ji). The test statistics is x2 = 
-2ln(r) where r = L(&o)/L(fia). If x2 2 ~~(g_~)(cy’) we reject Ho at the a’ level of 
significance and conclude that there is an overall experiment effect. 
If there is statistical evidence to suggest an overall experiment effect, techniques from 
multivariate analysis can be used to determine which pair(s) of vectors is(are) different. 
When this procedure implies two treatment groups differ, we apply similar techniques 
to isolate the factor(s) (a change in m and/or a change in p) contributing to this group 
difference [4] [5]. 
It is not necessary for all treatment groups to have the same number of animals, and 
if animals die prior to completion of the experiment, this estimation procedure can still 
be applied by modifying assumption 3 from above: 3. Animal i survives until time 
tT(< d). All surviving animals are sacrificed at time d [5). Animals that die prior to 
termination of an experiment provide valuable information that can be properly included 
in the analysis. A computer program is presently being written which implements the 
statistical procedures described in this paper. 
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